http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2654930-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c82f1477b71e93f1ff6e9b27d67ec77
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 2010-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_635b22917aa68a47594ab2b3af7c74a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7fcbbd451a92adbb6fe81d73c9589ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc2d098a58d8713fdd47a90c168d5c47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f35e6bd395089148afa7d493972ffe27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bda873bd8971b9b0f45055553ba0475d
publicationDate 2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2654930-T3
titleOfInvention Combinations of 5-HT4 receptor agonists and acetylcholinesterase inhibitors for the treatment of cognitive disorders
abstract 1-Isopropyl-2-oxo-1,2-dihydroquinolin-3-carboxylic acid {(1S, 3R, 5R) -8 - [(R) -2-hydroxy-3- (methanesulfonyl-methylamino) propyl] -8- azabicyclo [3.2.1] oct-3-yl} amide or a pharmaceutically acceptable salt thereof, in combination with an acetylcholinesterase inhibitor, for use in the treatment of Alzheimer's disease or a cognitive disorder.
priorityDate 2009-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423372810
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21872322
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10944290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452063286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516919
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54680660
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452523935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415748160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421183054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454668499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448277366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426166576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453552148
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53315106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23462

Total number of triples: 63.